MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2026 International Congress

    Nutritional status, clinical Features and lifestyle of Twins Discordant for Parkinson’s Disease

    M. Barichella, A. Natale, E. Cereda, E. Contaldi, L. Magistrelli, C. Bolliri, M. Macchione, F. Invernizzi, D. Calandrella, I. Isaias, G. Pezzoli (Milano, Italy)

    Objective: To characterize nutritional status (body weight, body mass index [BMI]), dietary habits, and lifestyle factors (smoking) of twins discordant for Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    The enteric footprint of de novo parkinson’s disease cohort: constipation, inflammation, and nulisa biomarker profiling.

    S. Enriquez Calzada, M. Miret Milian, L. Melgarejo, M. Arrué, A. López, S. Belmonte, M. Martinez-Vicente, J. Hernandez-Vara, A. Laguna (Barcelona, Spain)

    Objective: This study aimed to analyze constipation symptoms and blood, CSF and fecal biomarkers, including a High-plex Profiling of Inflammatory Proteins (NULISA) in a de novo PD cohort. Background: Parkinson’s disease…
  • 2026 International Congress

    A Tiered Fecal Biomarker Approach to Identify Gut–Brain Axis Phenotypes in Young-Onset Parkinsonism in a Clinical Setting with Limited Resources

    N. Raisa, F. Aushi (Malang, Indonesia)

    Objective: To explore the feasibility of a tiered fecal biomarker testing approach to identify potential gut–brain axis phenotypes in patients with young-onset parkinsonism in a…
  • 2026 International Congress

    Genetic Predictors in Dystonia: A Phenotypic Analysis.

    N. Gowda, N. Kamble, V. Holla, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To identify clinical predictors of genetic positivity in dystonia and to develop a phenotype-based predictive score to guide genetic testing. Background: Dystonia is a…
  • 2026 International Congress

    Engage in Healthy Eating: A Community-Guided Approach to Culturally Sensitive Nutrition Support for People with Parkinson’s Disease (PD)

    H. Shah, R. Gilbert, P. Purdy, L. Quinn, A. Parker, E. Adelman, A. Shiell, R. Pena, S. Lim (New York, USA)

    Objective: To co-develop a culturally affirming, family-centered Healthy Eating Program with community members for managing PD symptoms and achieving personal wellness goals. Background: Growing evidence…
  • 2026 International Congress

    A Pragmatic Phenotype-Guided Algorithm for Constipation in Parkinson’s Disease

    G. Hey, M. Beke, C. Rogers, A. Ramirez-Zamora, M. Amaris (Gainesville, USA)

    Objective: Evaluate the effect of a structured Mediterranean-style high fiber diet as the cornerstone of treatment with additional therapies layered when needed (FIBER-MED), using a…
  • 2026 International Congress

    Nutrition and Dietary Assessment as a Wellness Factor in Parkinson’s Disease and Related Disorders

    N. Hellmers, B. Katz, M. Bruno, H. Sarva (New York, USA)

    Objective: To characterize nutrition and food related concerns identified during supportive care visits for individuals with Parkinson’s disease (PD) and related disorders. Background: Individuals with…
  • 2025 International Congress

    Hyperbaric Oxygen Therapy for Parkinson’s disease via modulation of gut microbiota

    V. Vedam-Mai, J. Long, N. Nair, D. Fuller, K. Deegan, S. Rana, G. Iglesias, I. Gonzalez, U. Dissanayake, V. Mai (Gainesville, USA)

    Objective: To investigate the effect of hyperbaric oxygen therapy (HBOT) on gut microbiota in a preclinical model of PD. Background: Humans have coevolved with complex…
  • 2025 International Congress

    Advancements in Microbiome Research: Total Microbial Load, Differential Absolute Abundance, and Correlations with Immune Transcriptomics

    B. Palushaj, M. Chakraborty, I. Porter, G. Reynolds, E. Brooks, Z. He, A. Bhatt, K. Poston (Palo Alto, USA)

    Objective: Quantify total microbial load in the gut microbiome of people with Parkinson’s disease (PD) and compare the absolute abundance of bacterial taxa between PD…
  • 2025 International Congress

    Gastrointestinal Dysfunction and Levodopa Therapeutic Response in Parkinson’s Disease: A Brazilian Cross-sectional Study

    N. Dos Santos, G. de Vasconcelos, G. Piñeiro, F. Brito, J. Oliveira, S. Baran, J. Costa, E. Muricy, R. Kauark (Salvador, Brazil)

    Objective: To investigate the relation between constipation and the onset time of levodopa therapeutic effect in Parkinson's disease (PD). Background: Levodopa therapeutic response depends on…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley